Literature DB >> 8142118

Serum soluble interleukin-2 receptor in colorectal cancer.

S Murakami1, A Satomi, K Ishida, H Murai, Y Okamura.   

Abstract

Preoperative serum soluble interleukin-2 receptor (IL-2R) levels were measured in patients with colorectal cancer, and correlated with various factors as stage, lymph node metastasis, liver metastasis, grade, serum CEA and IAP (immunosuppressive acidic protein). The levels of serum soluble IL-2R in Dukes stage C were significantly higher than in normal control and in Dukes stage A. Serum levels were also significantly higher in patients with lymph node metastasis than in patients without such metastasis, and in IAP positive patients compared to IAP negative patients. Preoperative serum IL-2R levels thus seem to reflect the stage of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142118     DOI: 10.3109/02841869409098369

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  3 in total

1.  Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.

Authors:  H Saito; S Tsujitani; K Katano; M Ikeguchi; M Maeta; N Kaibara
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

2.  Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.

Authors:  N El Houda Agueznay; C Badoual; S Hans; A Gey; B Vingert; S Peyrard; F Quintin-Colonna; P Ravel; P Bruneval; S Roncelin; B Lelongt; J Bertoglio; W H Fridman; D Brasnu; E Tartour
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

3.  Relation between depression and circulating immune products in patients with advanced colorectal cancer.

Authors:  T G Allen-Mersh; C Glover; C Fordy; D C Henderson; M Davies
Journal:  J R Soc Med       Date:  1998-08       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.